Interaction of transcription factor AP‐2 gamma with proto‐oncogene PELP1 promotes tumorigenesis by enhancing RET signaling

A significant proportion of estrogen receptor‐positive (ER+) breast cancer (BC) initially responds to endocrine therapy but eventually evolves into therapy‐resistant BC. Transcription factor AP‐2 gamma (TFAP2C) is a known regulator of ER activity, and high expression of TFAP2C is associated with a d...

Cijeli opis

Bibliografski detalji

Glavni autori:	Junhao Liu, Zexuan Liu, Mengxing Li, Weiwei Tang, Uday P. Pratap, Yiliao Luo, Kristin A. Altwegg, Xiaonan Li, Yi Zou, Hong Zhu, Gangadhara R. Sareddy, Suryavathi Viswanadhapalli, Ratna K. Vadlamudi
Format:	Artigo
Jezik:	Inglês
Izdano:	Wiley 2021-04-01
Serija:	Molecular Oncology
Teme:	breast cancer coactivator PELP1 TFAP2C therapy resistance
Online pristup:	https://doi.org/10.1002/1878-0261.12871
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!